GLP-1 agonists show broad healthspan potential beyond diabetes but muscle loss and safety need solving
GLP-1 drugs demonstrate effects beyond glucose control and obesity, potentially improving healthy aging, but side effects like muscle loss require formulation advances before preventive use…